STOCK TITAN

Vanguard disaggregates holdings; Exelixis (NASDAQ: EXEL) shows 0 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Exelixis Inc ownership disclosure: The Vanguard Group filed an amendment stating it beneficially owns 0 shares of Exelixis common stock, representing 0% of the class. The filing notes an internal realignment on January 12, 2026 and cites "in accordance with SEC Release No. 34-39538 (January 12, 1998)."

The filing is signed by Ashley Grim, Head of Global Fund Administration, and lists The Vanguard Group's address in Malvern, Pennsylvania.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

What does the 13G/A filed by The Vanguard Group say about EXEL holdings?

The Vanguard Group reports holding 0 shares of Exelixis, or 0%. The amendment explains an internal realignment on January 12, 2026 and states certain subsidiaries now report separately under SEC Release No. 34-39538.

Does The Vanguard Group retain voting or dispositive power over EXEL shares?

No—The Vanguard Group reports 0 sole or shared voting and dispositive power. The filing lists zero for sole voting power, shared voting power, sole dispositive power, and shared dispositive power for Exelixis common stock.

Why does the filing reference SEC Release No. 34-39538 for EXEL?

The reference explains reporting changes after internal realignment. It states subsidiaries or business divisions now report beneficial ownership separately and The Vanguard Group no longer is deemed to beneficially own those subsidiary-held securities.

Who signed the SCHEDULE 13G/A amendment for EXEL on behalf of Vanguard?

The amendment is signed by Ashley Grim, Head of Global Fund Administration. The filing includes The Vanguard Group's Malvern, Pennsylvania address and the signature date of 03/26/2026.

Does the filing indicate any holder owns more than 5% of EXEL on Vanguard's behalf?

The Vanguard Group states no other person's interest exceeds 5%. The filing notes investment companies and managed accounts within Vanguard have rights to dividends or proceeds, but no single person holds more than 5% per the statement.
Exelixis Inc

NASDAQ:EXEL

View EXEL Stock Overview

EXEL Rankings

EXEL Latest News

EXEL Latest SEC Filings

EXEL Stock Data

11.00B
253.59M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
ALAMEDA